Up to now, schizophrenia has mainly been treated symptomatically, as little is known about the exact underlying processes.

We improve our service by using Microsoft Clarity to see how you use our website. By using our site, you agree that we and Microsoft can collect and use this data. Our privacy notice has more details.

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

Dr. Christopher Seet, an assistant professor of hematology-oncology at the David Geffen School of Medicine at UCLA, has received a $2.9 million R37 MERIT Award from the National Cancer Institute to ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Keros Therapeutics (KROS – Research Report), ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Next, using fluorescent dyes attached to ApoE or to its lipid cargoes, the scientists found that lipidated ApoE3 and ApoE4 readily infiltrated a variety of cells, including H4 neuroglioma cells and ...

We combed through Target for the best Black Friday deals still live today, so all that’s left for you to do is show up and check out while you still can.

The Black Friday deals are officially here, and there are some awesome deals to be had at Target. If you're a gamer, Target is offering great deals on the PS5 Slim Digital Edition, which is a huge ...

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and ...

If you need to make a last-minute run to the grocery store to pick up something for your holiday gathering, Target will not be an option for you this year, as the company told USA TODAY their ...